Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-perio (Q33445235)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-perio |
scientific article |
Statements
1 reference
Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-perio (English)
1 reference
Gavin R Graff
1 reference
Karen Maguiness
1 reference
John McNamara
1 reference
Ronald Morton
1 reference
David Boyd
1 reference
Katrin Beckmann
1 reference
Djenane Bennett
1 reference
1 January 2010
1 reference
1 reference
32
1 reference
89-103
1 reference
Identifiers
1 reference
1 reference